Announcement on Receiving FDA's Approval for Clinical Trial of KYS202004A Injection

About this update from Jiangsu Kanion Pharmaceutical Co. Ltd. Class A

Announcement on Receiving FDA's Approval for Clinical Trial of KYS202004A InjectionThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Jiangsu Kanion Pharmaceutical Co. Ltd. Class A